Evolut Low Risk
2019
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients
In 1,468 patients with severe AS at low surgical risk, TAVR with a self-expanding valve was non-inferior to surgical aortic-valve replacement for death or disabling stroke at 2 years.
Result
- Absolute difference
- 1.4 points
The absolute difference is derived from the event rates.
Also reported: (non-inferior); benefit persists at 4 years.
- Subtopic
- TAVR
- Design
- RCT, non-inferiority
- Relevance
- Important: one of several pillars.
- Cited in
- ESC 2025 VHDACC/AHA 2020 VHD
- Source
- Popma JJ, et al. N Engl J Med. 2019;380(18):1706-1715.doi 10.1056/NEJMoa1816885
Discussion & critique
With PARTNER 3, extended TAVR to low-risk patients. Self-expanding valves bring more pacemakers; long-term durability data are still maturing.